Alamar Biosciences Inc (ALMR)

$22.00 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 74.21M
Net Income (ttm) -29.82M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -40.18%
Debt to Equity Ratio N/A
Volume 1,069,200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, tr...

Industry: Medical Devices
Sector: Healthcare
Phone: (510) 626-9888
Fax: (510) 605-5062
Address:
47071 Bayside Parkway, Fremont, United States
Cache_Money
Cache_Money Aug. 19 at 2:34 PM
$ALMR Starting a small position here for a long-term hold
0 · Reply
healthcareguru
healthcareguru Aug. 17 at 4:26 PM
$ALMR Repeat: This is getting cut in HALF. One of the most egregious valuations in the entire market and barreling into IPO lockup expiry where >40% of shares held by VCs are getting dumped… TIMBER!! 👎🐺 $XLV $XBI $IWM
0 · Reply
Zephix
Zephix Aug. 13 at 11:03 PM
$ALMR $CLPR vvs26
0 · Reply
healthcareguru
healthcareguru Aug. 12 at 2:33 PM
$ALMR See you at $20 soon…juice has been squeezed. IPO lockup expiry is gonna be a MASSACRE. Most expensive valuation of any stock on earth. >30x EV/GP on 2027e… 😂😂😂😂😂😂😂😂😂👎👎👎👎👎 $XLV $XBI $IWM
0 · Reply
topstockalerts
topstockalerts Aug. 11 at 7:29 PM
Top Gainers PT2 $NIQ $TISI $FRTT $ALMR $GRI
0 · Reply
healthcareguru
healthcareguru Aug. 11 at 6:11 PM
$ALMR shorting every day…most overvalued stock I’ve ever seen!!! Pure Lunacy!! Can’t wait for IPO lockup to cut this in half. You were warned. 🤦‍♂️👎 $XLV $IWM
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 10 at 9:43 PM
$ALMR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.22 up 64.52% YoY • Reported revenue of $29.43M up 82.08% YoY • Alamar Biosciences expects full year 2026 revenue to be in the range of $116 million to $120 million, representing growth of 59% at the midpoint of the range compared to 2025.
0 · Reply
EarningsInsider
EarningsInsider Aug. 10 at 9:31 PM
https://www.marketbeat.com/earnings/reports/2026-8-10-alamar-biosciences-inc-stock/ $ALMR Alamar Biosciences Earnings Transcript
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Jul. 8 at 2:47 AM
Alamar's New Blood Test Could Rapidly Advance Alzheimer's Research: https://jlsfund.substack.com/p/alamars-new-blood-test-could-rapidly $ALMR
0 · Reply
IsabellaDC
IsabellaDC Jun. 25 at 3:49 PM
All time high scan: $KYMR $MU $ALMR $ASND $GLW and so on.
0 · Reply
Latest News on ALMR
Alamar Biosciences price target raised to $31 from $30 at BofA

2026-08-11T13:20:16.000Z - 8 days ago

Alamar Biosciences price target raised to $31 from $30 at BofA

Alamar Biosciences price target raised to $32 from $28 at Stifel

2026-08-11T11:42:32.000Z - 8 days ago

Alamar Biosciences price target raised to $32 from $28 at Stifel

Alamar Biosciences price target raised to $35 from $32 at JPMorgan

2026-08-11T11:32:19.000Z - 8 days ago

Alamar Biosciences price target raised to $35 from $32 at JPMorgan

Alamar Biosciences expands Alzheimer’s Data Initiative deal with 86K samples

2026-08-10T21:10:09.000Z - 8 days ago

Alamar Biosciences expands Alzheimer’s Data Initiative deal with 86K samples

Alamar Biosciences reports Q2 EPS (22c), consensus (32c)

2026-08-10T20:35:41.000Z - 8 days ago

Alamar Biosciences reports Q2 EPS (22c), consensus (32c)

Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M

2026-08-10T20:35:37.000Z - 8 days ago

Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M

Alamar Biosciences Earnings Call Transcript: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 8 days ago

Alamar Biosciences Earnings Call Transcript: Q2 2026

Alamar Biosciences Earnings release: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 8 days ago

Alamar Biosciences Earnings release: Q2 2026

Alamar Biosciences Slides: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 8 days ago

Alamar Biosciences Slides: Q2 2026

Alamar Biosciences Quarterly report: Q2 2026

Aug 10, 2026, 4:30 PM EDT - 8 days ago

Alamar Biosciences Quarterly report: Q2 2026

Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome

Jul 28, 2026, 4:12 PM EDT - 21 days ago

Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome

Alamar Biosciences price target raised to $34 from $30 at TD Cowen

2026-07-15T12:46:19.000Z - 5 weeks ago

Alamar Biosciences price target raised to $34 from $30 at TD Cowen

Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026

Jul 14, 2026, 4:05 PM EDT - 5 weeks ago

Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026

Alamar teams with research universities to launch proteomics initiatives

2026-07-13T09:20:12.000Z - 5 weeks ago

Alamar teams with research universities to launch proteomics initiatives

Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

Jul 13, 2026, 2:30 AM EDT - 5 weeks ago

Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling

Jul 10, 2026, 6:11 AM EDT - 5 weeks ago

Alamar Biosciences NULISA Data Featured in More Than 140 Scientific Presentations at AAIC 2026, Highlighting Advances in Blood-Based Alzheimer's Biomarker Profiling

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer's Disease Research

Jul 7, 2026, 9:12 AM EDT - 6 weeks ago

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer's Disease Research

Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics

Jun 2, 2026, 8:11 AM EDT - 2 months ago

Alamar Biosciences Makes Home-Collected Fingerstick Samples Compatible with Ultra High-Sensitivity, Multiplex Proteomics

Alamar Biosciences Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 6:40 PM EDT - 3 months ago

Alamar Biosciences Transcript: Bank of America Global Healthcare Conference 2026

Alamar Biosciences Slides: FY 2026

May 12, 2026, 6:40 PM EDT - 3 months ago

Alamar Biosciences Slides: FY 2026

Alamar Biosciences initiated with an Outperform at Leerink

2026-05-12T17:01:10.000Z - 3 months ago

Alamar Biosciences initiated with an Outperform at Leerink

Alamar Biosciences initiated with a Neutral at BofA

2026-05-12T10:40:44.000Z - 3 months ago

Alamar Biosciences initiated with a Neutral at BofA

Alamar Biosciences initiated with a Buy at TD Cowen

2026-05-12T09:36:32.000Z - 3 months ago

Alamar Biosciences initiated with a Buy at TD Cowen

Alamar Biosciences initiated with an Overweight at JPMorgan

2026-05-12T08:41:24.000Z - 3 months ago

Alamar Biosciences initiated with an Overweight at JPMorgan

Alamar Biosciences initiated with a Buy at Stifel

2026-05-12T08:40:45.000Z - 3 months ago

Alamar Biosciences initiated with a Buy at Stifel

Alamar Biosciences reports Q1 EPS ($1.74) vs. (68c) last year

2026-05-08T18:02:51.000Z - 3 months ago

Alamar Biosciences reports Q1 EPS ($1.74) vs. (68c) last year

Alamar Biosciences Earnings release: Q1 2026

May 8, 2026, 9:30 AM EDT - 3 months ago

Alamar Biosciences Earnings release: Q1 2026

Alamar Biosciences Quarterly report: Q1 2026

May 8, 2026, 9:30 AM EDT - 3 months ago

Alamar Biosciences Quarterly report: Q1 2026

Alamar Biosciences Reports First Quarter 2026 Financial Results

May 8, 2026, 8:00 AM EDT - 3 months ago

Alamar Biosciences Reports First Quarter 2026 Financial Results

Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference

May 5, 2026, 4:05 PM EDT - 3 months ago

Alamar Biosciences to Participate in BofA Securities 2026 Healthcare Conference

Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026

Apr 30, 2026, 4:05 PM EDT - 3 months ago

Alamar Biosciences to Report First Quarter 2026 Financial Results on May 8, 2026

Alamar Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Apr 20, 2026, 4:05 PM EDT - 4 months ago

Alamar Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

Apr 20, 2026, 3:09 AM EDT - 4 months ago

Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ

Cathie Wood’s ARK Investment buys 537.5K shares of Alamar Biosciences today

2026-04-18T00:10:12.000Z - 4 months ago

Cathie Wood’s ARK Investment buys 537.5K shares of Alamar Biosciences today

Alamar Biosciences valued at $1.5 billion as shares jump in Nasdaq debut

Apr 17, 2026, 12:45 PM EDT - 4 months ago

Alamar Biosciences valued at $1.5 billion as shares jump in Nasdaq debut

Alamar Biosciences Announces Pricing of Upsized Initial Public Offering

Apr 16, 2026, 9:15 PM EDT - 4 months ago

Alamar Biosciences Announces Pricing of Upsized Initial Public Offering

Alamar Biosciences Registration statement: Registration filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Alamar Biosciences Registration statement: Registration filing

Alamar Biosciences Registration statement: Registration filing

Apr 13, 2026, 8:00 AM EDT - 4 months ago

Alamar Biosciences Registration statement: Registration filing

Protein biomarker detection platform Alamar Biosciences files for a $100 million IPO

Mar 27, 2026, 5:12 PM EDT - 5 months ago

Protein biomarker detection platform Alamar Biosciences files for a $100 million IPO

Alamar Biosciences IPO Registration Document (S-1)

Mar 27, 2026, 4:12 PM EDT - 5 months ago

Alamar Biosciences IPO Registration Document (S-1)

Cache_Money
Cache_Money Aug. 19 at 2:34 PM
$ALMR Starting a small position here for a long-term hold
0 · Reply
healthcareguru
healthcareguru Aug. 17 at 4:26 PM
$ALMR Repeat: This is getting cut in HALF. One of the most egregious valuations in the entire market and barreling into IPO lockup expiry where >40% of shares held by VCs are getting dumped… TIMBER!! 👎🐺 $XLV $XBI $IWM
0 · Reply
Zephix
Zephix Aug. 13 at 11:03 PM
$ALMR $CLPR vvs26
0 · Reply
healthcareguru
healthcareguru Aug. 12 at 2:33 PM
$ALMR See you at $20 soon…juice has been squeezed. IPO lockup expiry is gonna be a MASSACRE. Most expensive valuation of any stock on earth. >30x EV/GP on 2027e… 😂😂😂😂😂😂😂😂😂👎👎👎👎👎 $XLV $XBI $IWM
0 · Reply
topstockalerts
topstockalerts Aug. 11 at 7:29 PM
Top Gainers PT2 $NIQ $TISI $FRTT $ALMR $GRI
0 · Reply
healthcareguru
healthcareguru Aug. 11 at 6:11 PM
$ALMR shorting every day…most overvalued stock I’ve ever seen!!! Pure Lunacy!! Can’t wait for IPO lockup to cut this in half. You were warned. 🤦‍♂️👎 $XLV $IWM
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 10 at 9:43 PM
$ALMR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.22 up 64.52% YoY • Reported revenue of $29.43M up 82.08% YoY • Alamar Biosciences expects full year 2026 revenue to be in the range of $116 million to $120 million, representing growth of 59% at the midpoint of the range compared to 2025.
0 · Reply
EarningsInsider
EarningsInsider Aug. 10 at 9:31 PM
https://www.marketbeat.com/earnings/reports/2026-8-10-alamar-biosciences-inc-stock/ $ALMR Alamar Biosciences Earnings Transcript
0 · Reply
LibertarianTreehugger
LibertarianTreehugger Jul. 8 at 2:47 AM
Alamar's New Blood Test Could Rapidly Advance Alzheimer's Research: https://jlsfund.substack.com/p/alamars-new-blood-test-could-rapidly $ALMR
0 · Reply
IsabellaDC
IsabellaDC Jun. 25 at 3:49 PM
All time high scan: $KYMR $MU $ALMR $ASND $GLW and so on.
0 · Reply
notreload_ai
notreload_ai May. 12 at 1:31 PM
$AVEX $ALMR $BRUN $DXCM $BSY -- THE WSJ
0 · Reply
Marmot1
Marmot1 May. 8 at 9:36 PM
$ALMR keep an eye on this company!
0 · Reply
RB212
RB212 Apr. 27 at 9:17 PM
$ALMR currently watching but interested
0 · Reply
Vetiver
Vetiver Apr. 23 at 8:50 AM
$ALMR might start a position here during correction. promising tech.
0 · Reply